After all, the biotech's valuation is still fairly attractive, as its shares trade at less than 5x projected sales. All things considered, Acadia's shares ought to perform reasonably well over the ...

A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and ...

DUBLIN--(BUSINESS WIRE)--The "Red Biotechnology Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's ...

Like other mature drug manufacturers, Eli Lilly and Company (NYSE: LLY) is banking on innovative biotechnology platforms ... The only thing hotter than Lilly’s share price is its valuation.

In particular, there are three things to pay attention to that'll give ... For a pre-product biotech, the best SABs are staffed with the leading researchers in the field of science that's the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Where are the stock market leaders? I asked this all-important question in a recent RiskHedge Report… and the answer I found was not good. A healthy market needs at least one strong sector to ...

gamblers may nevertheless want to consider the merits of targeting potentially lucrative biotech stocks that could be the next big thing. These lesser-known enterprises may not command worldwide ...

It should be noted that the biotech sector always provides a higher beta than the overall market, but recent trading action has been marked by significant volatility. There are two key things to ...